BridgeMD
Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)
EU CTIS ID: 2022-501133-23-00
What this study is testing
To Study the effectiveness of high-throughput oxygen therapy on migraine attacks in emergency departments.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients 18 years of age or older
- Admitted to the emergency department for migraine-evocative headache according to the criteria of the International Classification of Headaches 3rd edition ICHD-3
- Written consent to participate after being informed of the study
- Pain intensity at least equal to 6 assessed by the patient’s verbal pain self-assessment
You likely can't join if
- Patients with risk of respiratory failure by hypercapnia (COPD, cystic fibrosis, morbid obesity, malformation of the chest wall, neuromuscular disorder)
- Patients under legal protection
- Patients treated with triptan in the last 2 weeks
- Patients who consumed NSAIDs in the hour prior to physician review
- Disabling migraine crisis during for more than 72 hours
- History of paraquat poisoning
See the full eligibility criteria
- Patients 18 years of age or older
- Admitted to the emergency department for migraine-evocative headache according to the criteria of the International Classification of Headaches 3rd edition ICHD-3
- Written consent to participate after being informed of the study
- Pain intensity at least equal to 6 assessed by the patient’s verbal pain self-assessment
- Patients with risk of respiratory failure by hypercapnia (COPD, cystic fibrosis, morbid obesity, malformation of the chest wall, neuromuscular disorder)
- Patients under legal protection
- Patients treated with triptan in the last 2 weeks
- Patients who consumed NSAIDs in the hour prior to physician review
- Disabling migraine crisis during for more than 72 hours
- History of paraquat poisoning
- History of treatment with amiodarone, bleomycin or nitrofurantoin
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.